BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35626644)

  • 21. Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.
    Wang H; Moniruzzaman R; Li L; Ji B; Liu Y; Zuo X; Abbasgholizadeh R; Zhao J; Liu G; Wang R; Tang H; Sun R; Su X; Tan TH; Maitra A; Wang H
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37140994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic intermittent hypoxia (CIH) on neuromuscular junctions and mitochondria in slow- and fast-twitch skeletal muscles of mice-the role of iNOS.
    Bannow LI; Bonaterra GA; Bertoune M; Maus S; Schulz R; Weissmann N; Kraut S; Kinscherf R; Hildebrandt W
    Skelet Muscle; 2022 Feb; 12(1):6. PubMed ID: 35151349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.
    Dumartin L; Alrawashdeh W; Trabulo SM; Radon TP; Steiger K; Feakins RM; di Magliano MP; Heeschen C; Esposito I; Lemoine NR; Crnogorac-Jurcevic T
    Oncogene; 2017 Jun; 36(22):3094-3103. PubMed ID: 27941872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic KRAS, Mucin 4, and Activin A-Mediated Fibroblast Activation Cooperate for PanIN Initiation.
    Hu CM; Huang CC; Hsu MF; Chien HJ; Wu PJ; Chen YI; Jeng YM; Tang SC; Chung MH; Shen CN; Chang MC; Chang YT; Tien YW; Lee WH
    Adv Sci (Weinh); 2023 Dec; 10(36):e2301240. PubMed ID: 37964407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.
    Carrière C; Gore AJ; Norris AM; Gunn JR; Young AL; Longnecker DS; Korc M
    Gastroenterology; 2011 Sep; 141(3):1091-101. PubMed ID: 21699781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.
    Murphy SJ; Hart SN; Lima JF; Kipp BR; Klebig M; Winters JL; Szabo C; Zhang L; Eckloff BW; Petersen GM; Scherer SE; Gibbs RA; McWilliams RR; Vasmatzis G; Couch FJ
    Gastroenterology; 2013 Nov; 145(5):1098-1109.e1. PubMed ID: 23912084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ANGPTL4 accelerates KRAS
    Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
    Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.
    Shi G; DiRenzo D; Qu C; Barney D; Miley D; Konieczny SF
    Oncogene; 2013 Apr; 32(15):1950-8. PubMed ID: 22665051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.
    De La O JP; Murtaugh LC
    Cell Cycle; 2009 Jun; 8(12):1860-4. PubMed ID: 19440048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.
    Bailey JM; Alsina J; Rasheed ZA; McAllister FM; Fu YY; Plentz R; Zhang H; Pasricha PJ; Bardeesy N; Matsui W; Maitra A; Leach SD
    Gastroenterology; 2014 Jan; 146(1):245-56. PubMed ID: 24096005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
    Humpton TJ; Alagesan B; DeNicola GM; Lu D; Yordanov GN; Leonhardt CS; Yao MA; Alagesan P; Zaatari MN; Park Y; Skepper JN; Macleod KF; Perez-Mancera PA; Murphy MP; Evan GI; Vousden KH; Tuveson DA
    Cancer Discov; 2019 Sep; 9(9):1268-1287. PubMed ID: 31263025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NEMO/NF-κB signaling functions as a double-edged sword in PanIN formation versus progression to pancreatic cancer.
    Tsesmelis M; Büttner UFG; Gerstenlauer M; Manfras U; Tsesmelis K; Du Z; Sperb N; Weissinger SE; Möller P; Barth TFE; Maier HJ; Chan LK; Wirth T
    Mol Cancer; 2024 May; 23(1):103. PubMed ID: 38755681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.